{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:31:44Z","timestamp":1790285504648,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01396-x","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T06:54:35Z","timestamp":1770879275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A randomised trial of a bioreactor-produced EV-A71 vaccine for endemic control in children"],"prefix":"10.1038","volume":"11","author":[{"given":"Kao-Pin","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quang Chan","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yhu-Chering","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chou-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuc Hong","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Tuyet","family":"Thi Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon-Fatt","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi Thanh","family":"Thao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pochun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chwen-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Fen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"1396_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/aje\/kwy238","volume":"188","author":"B Yang","year":"2019","unstructured":"Yang, B., Lau, E. H. Y. & Cowling, B. J. Estimating the severity profile of enterovirus A71 infections in children: a Bayesian synthesis framework. Am. J. Epidemiol. 188, 475\u2013483 (2019).","journal-title":"Am. J. Epidemiol."},{"key":"1396_CR2","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1590\/s1678-9946201860070","volume":"60","author":"YK Chang","year":"2018","unstructured":"Chang, Y. K., Chen, K. H. & Chen, K. T. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development. Rev. Inst. Med. Trop. Sao Paulo 60, e70 (2018).","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"1396_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12929-019-0552-7","volume":"26","author":"LY Chang","year":"2019","unstructured":"Chang, L. Y. et al. Enterovirus A71 neurologic complications and long-term sequelae. J. Biomed. Sci. 26, 57 (2019).","journal-title":"J. Biomed. Sci."},{"key":"1396_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12929-019-0574-1","volume":"26","author":"SW Huang","year":"2019","unstructured":"Huang, S. W., Cheng, D. & Wang, J. R. Enterovirus A71: virulence, antigenicity, and genetic evolution over the years. J. Biomed. Sci. 26, 81 (2019).","journal-title":"J. Biomed. Sci."},{"key":"1396_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12929-019-0573-2","volume":"26","author":"J Puenpa","year":"2019","unstructured":"Puenpa, J. et al. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J. Biomed. Sci. 26, 75 (2019).","journal-title":"J. Biomed. Sci."},{"key":"1396_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13916-0","volume":"22","author":"YL Hu","year":"2022","unstructured":"Hu, Y. L. et al. The secular trend of enterovirus A71 after the implementation of preventive measures in Taiwan. BMC Public Health 22, 1483 (2022).","journal-title":"BMC Public Health"},{"key":"1396_CR7","doi-asserted-by":"publisher","first-page":"e0004562","DOI":"10.1371\/journal.pntd.0004562","volume":"10","author":"N NikNadia","year":"2016","unstructured":"NikNadia, N. et al. Cyclical patterns of hand, foot and mouth disease caused by enterovirus A71 in Malaysia. PLoS Negl. Trop. Dis. 10, e0004562 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1396_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3345\/kjp.2016.59.10.395","volume":"59","author":"KY Lee","year":"2016","unstructured":"Lee, K. Y. Enterovirus 71 infection and neurological complications. Korean J. Pediatr. 59, 395\u2013401 (2016).","journal-title":"Korean J. Pediatr."},{"key":"1396_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJM199909233411301","volume":"341","author":"M Ho","year":"1999","unstructured":"Ho, M. et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 341, 929\u2013935 (1999).","journal-title":"N. Engl. J. Med."},{"key":"1396_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jpids\/pit017","volume":"2","author":"S Gantt","year":"2013","unstructured":"Gantt, S. et al. Implications of age-dependent immune responses to enterovirus 71 infection for disease pathogenesis and vaccine design. J. Pediatr. Infect. Dis. Soc. 2, 162\u2013170 (2013).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"1396_CR11","first-page":"100284","volume":"16","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial. Lancet Reg. Health West Pac. 16, 100284 (2021).","journal-title":"Lancet Reg. Health West Pac."},{"key":"1396_CR12","doi-asserted-by":"crossref","unstructured":"Yee, P. T. & Poh, C. L. Development of novel vaccines against enterovirus-71. Viruses 8, 1 (2015).","DOI":"10.3390\/v8010001"},{"key":"1396_CR13","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.vaccine.2013.03.015","volume":"31","author":"A Cheng","year":"2013","unstructured":"Cheng, A. et al. A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine. Vaccine 31, 2471\u20132476 (2013).","journal-title":"Vaccine"},{"key":"1396_CR14","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.1016\/j.vaccine.2019.07.096","volume":"37","author":"MC Hung","year":"2019","unstructured":"Hung, M. C. et al. Immunogenicity and safety of an inactivated enterovirus A71 vaccine in children 3-6 years and 2-35 months of age- an open-label, randomized phase IIb clinical trial. Vaccine 37, 5559\u20135566 (2019).","journal-title":"Vaccine"},{"key":"1396_CR15","doi-asserted-by":"crossref","unstructured":"Li, M. L. et al. Enterovirus A71 vaccines. Vaccines 9, 199 (2021).","DOI":"10.3390\/vaccines9030199"},{"key":"1396_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/iid3.26","volume":"2","author":"M Duchamp","year":"2014","unstructured":"Duchamp, M. et al. B-cell subpopulations in children: national reference values. Immun. Inflamm. Dis. 2, 131\u2013140 (2014).","journal-title":"Immun. Inflamm. Dis."},{"key":"1396_CR17","doi-asserted-by":"publisher","first-page":"595297","DOI":"10.3389\/fimmu.2020.595297","volume":"11","author":"EC Semmes","year":"2020","unstructured":"Semmes, E. C. et al. Understanding early-life adaptive immunity to guide interventions for pediatric health. Front. Immunol. 11, 595297 (2020).","journal-title":"Front. Immunol."},{"key":"1396_CR18","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1128\/CVI.00491-13","volume":"20","author":"YM Hu","year":"2013","unstructured":"Hu, Y. M. et al. Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months. Clin. Vaccin. Immunol. 20, 1805\u20131811 (2013).","journal-title":"Clin. Vaccin. Immunol."},{"key":"1396_CR19","doi-asserted-by":"publisher","first-page":"831282","DOI":"10.1155\/2012\/831282","volume":"2012","author":"AH Chou","year":"2012","unstructured":"Chou, A. H. et al. Immunological evaluation and comparison of different EV71 vaccine candidates. Clin. Dev. Immunol. 2012, 831282 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"1396_CR20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/20477724.2024.2400424","volume":"118","author":"CY Huang","year":"2024","unstructured":"Huang, C. Y., Su, S. B. & Chen, K. T. A review of enterovirus-associated hand-foot and mouth disease: preventive strategies and the need for a global enterovirus surveillance network. Pathog. Glob. Health 118, 538\u2013548 (2024).","journal-title":"Pathog. Glob. Health"},{"key":"1396_CR21","doi-asserted-by":"crossref","unstructured":"Liu, X. et al. Immunogenicity and safety of an inactivated enterovirus 71 vaccine administered simultaneously with hepatitis B virus vaccine, group a meningococcal polysaccharide vaccine, measles-rubella combined vaccine and Japanese encephalitis vaccine: a multi-center, randomized, controlled clinical trial in China. Vaccines 10, 895 (2022).","DOI":"10.3390\/vaccines10060895"},{"key":"1396_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3201\/eid3002.231024","volume":"30","author":"NVV Chau","year":"2024","unstructured":"Chau, N. V. V. et al. Emerging enterovirus A71 subgenogroup b5 causing severe hand, foot, and mouth disease, Vietnam, 2023. Emerg. Infect. Dis. 30, 363\u2013367 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"1396_CR23","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1128\/JCM.00542-06","volume":"44","author":"WA Nix","year":"2006","unstructured":"Nix, W. A., Oberste, M. S. & Pallansch, M. A. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J. Clin. Microbiol 44, 2698\u20132704 (2006).","journal-title":"J. Clin. Microbiol"},{"key":"1396_CR24","doi-asserted-by":"publisher","first-page":"e34834","DOI":"10.1371\/journal.pone.0034834","volume":"7","author":"AH Chou","year":"2012","unstructured":"Chou, A. H. et al. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates. PLoS One 7, e34834 (2012).","journal-title":"PLoS One"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01396-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:02:40Z","timestamp":1774310560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01396-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1396"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01396-x","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.T.L., S.T.L., C.C.L., and C.F.Y. are employees of Enimmune Corporation, the funder and sponsor of the study. P.C.L. and C.C.C. are employees of Adimmune Corporation, the parent company of Enimmune Corporation. The other authors do not have a competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}